{"data":[{"accessionNo":"0002012383-26-003844","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001390478","issuerName":"SELLAS LIFE SCIENCES GROUP INC","ticker":"SLS","cusip":"81642T209","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":15872685,"percentOfClass":7.9,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0000093751-26-000539","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001390478","issuerName":"SELLAS LIFE SCIENCES GROUP INC","ticker":"SLS","cusip":"81642T209","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":12996558,"percentOfClass":7,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0002100119-26-001315","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group Inc","ticker":"SLS","cusip":"81642T209","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":9666278,"percentOfClass":5.19,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0002012383-26-001466","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001390478","issuerName":"SELLAS LIFE SCIENCES GROUP INC","ticker":"SLS","cusip":"81642T209","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":12136331,"percentOfClass":6.8,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0000102909-26-002236","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group Inc","ticker":"SLS","cusip":"81642T209","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0001193125-26-053508","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Anson Funds Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":7481178,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0001193125-26-053508","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Anson Management GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":7481178,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0001193125-26-053508","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Tony Moore","reportingCik":null,"personType":"HC,IN","sharesOwned":7481178,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0001193125-26-053508","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Anson Advisors Inc.","reportingCik":null,"personType":"FI,CO","sharesOwned":7481178,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0001193125-26-053508","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Amin Nathoo","reportingCik":null,"personType":"HC,IN","sharesOwned":7481178,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0001193125-26-053508","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Moez Kassam","reportingCik":null,"personType":"HC,IN","sharesOwned":7481178,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0000902664-26-000615","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Highbridge Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":6514658,"percentOfClass":3.7,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0001193125-25-282690","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Anson Funds Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":6032938,"percentOfClass":5.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0001193125-25-282690","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Anson Management GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":6032938,"percentOfClass":5.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0001193125-25-282690","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Tony Moore","reportingCik":null,"personType":"HC,IN","sharesOwned":6032938,"percentOfClass":5.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0001193125-25-282690","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Anson Advisors Inc.","reportingCik":null,"personType":"FI,CO","sharesOwned":6032938,"percentOfClass":5.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0001193125-25-282690","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Amin Nathoo","reportingCik":null,"personType":"HC,IN","sharesOwned":6032938,"percentOfClass":5.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0001193125-25-282690","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001390478","issuerName":"SELLAS Life Sciences Group, Inc.","ticker":"SLS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Moez Kassam","reportingCik":null,"personType":"HC,IN","sharesOwned":6032938,"percentOfClass":5.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/sls"},{"accessionNo":"0002012383-25-002700","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001390478","issuerName":"SELLAS LIFE SCIENCES GROUP INC","ticker":"SLS","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":5686886,"percentOfClass":5.4,"filedAt":"2025-10-17","canonicalUrl":"https://xoomar.com/markets/stocks/sls"}],"updatedAt":"2026-11-04T07:01:47.717Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/sls","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}